logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
B

Bruno Sepodes

european medicines agency

37H指数
173论文数
4.2K被引数
收录论文 91
发表时间
logo
Two trials or not two trials? That should not be the question两个试验还是不进行两个试验？那不应该是问题
errNature Reviews Drug Discovery
IF101.8
err2026-09-21
err0
PREAI
errPeter Arlett; Steffen Thirstrup; Francesca Day; Juan Garcia Burgos; Nacho Mbaeliachi; Paolo Foggi; Kit Roes; Emer Cooke; Bruno Sepodes
err分享
err收藏
European stakeholders’ views on ethics aspects of patient registries: a survey study欧洲利益相关者对患者登记伦理问题的看法：一项调查研究
errBMC Medical Ethics
IF3.1
err2026-08-01
err0
errOAAI
errFabian Windfuhr; Olmo R. van den Akker; Björn Wettermark; Diogo Almeida; Bruno Sepodes; Carla Torre; Jana Hlaváčová; Peter G. M. Mol; Sieta T. de Vries
err分享
err收藏
European Medicines Agency multi-stakeholder workshop on innovation in cardiovascular medicines and medical devices in the EU欧洲药品管理局关于欧盟心血管药物和医疗器械创新的多利益相关方研讨会
errLancet Regional Health-Europe
IF13
err2026-07-22
err0
errOAAI
errSteffen Thirstrup; Bruno Sepodes; Iana Simova; Daniel Prieto-Alhambra; Patrice Verpillat; Luis Pinheiro; Mattias Van Heetvelde; Patrick Vrijlandt; Alar Irs; Silvy da Rocha Dias; Miguel Antunes; Nacho Mbaeliachi; Anna Baczynska; Pooja Jha
err分享
err收藏
European Medicines Agency approvals of new medicines in May and June 2026欧洲药品管理局2026年5月和6月的新药批准
errThe Lancet Regional Health - Europe
IF0
err2026-07-08
err0
errOAAI
errBruno Sepodes; Juan Garcia Burgos; Steffen Thirstrup
err分享
err收藏
Trends in EU regulatory assessment of oncology medicines欧盟肿瘤药物监管评估的趋势
errESMO Open
IF8.3
err2026-05-21
err0
errOAAI
errT. Pabsch; F. Pignatti; F. Day; B. Sepodes; H. Enzmann
err分享
err收藏
European medicines agency approvals of new medicines in January and February 2026欧洲药品管理局在2026年1月和2月对新药审批
errThe Lancet Regional Health - Europe
IF0
err2026-03-19
err0
errOAAI
errBruno Sepodes; Juan Garcia Burgos; Steffen Thirstrup
err分享
err收藏
Safety population size and duration of exposure prior to approval of new medicines: A database analysis of medicines centralised approved in the European Union between 2011 and 2023新药批准前安全人群规模和暴露持续时间：2011年至2023年欧盟集中审批药物的数据库分析
errPLoS One
IF2.6
err2026-02-09
err0
PREAI
errBouwman, Luisa; Leufkens, Hubert; Sepodes, Bruno; Torre, Carla
err分享
err收藏
The European medicines agency review of belzutifan (Welireg) for the treatment of adult patients with von Hippel-Lindau disease-associated tumors欧洲药品管理局对用于治疗成人冯·希佩尔-林道病相关肿瘤的belzutifan（Welireg）的审查
errOncologist
IF4.2
err2026-02-01
err1
PREAI
errBaron, Antonella; Broekman, Esther; van Gils, Martijn; Poplavska, Elita; Mol, Peter; Saliete, Ieva; Sepodes, Bruno; Pean, Elias
err分享
err收藏
Three decades of clinical trials in Portuguese-speaking Africa: a comprehensive scoping review protocol三十年葡萄牙语非洲临床试验：一项全面的范围综述方案
errBMJ Open
IF2.3
err2026-01-13
err0
errOAAI
errBatista, Jorge Pedro Barroso; Teixeira, Maria Manuel; Torre, Carla De Matos; Sepodes, Bruno; Abecasis, Ana; Mota-Filipe, Helder
err分享
err收藏
European Medicines Agency approvals of new medicines in November and December 2025欧洲药品管理局在2025年11月和12月批准的新药
errThe Lancet Regional Health - Europe
IF0
err2026-01-08
err0
errOAAI
errBruno Sepodes; Juan Garcia Burgos; Steffen Thirstrup
err分享
err收藏
The European Medicines Agency's review of elexacaftor/ tezacaftor/ivacaftor: extending its use to all people with cystic fibrosis aged 2 years and older who do not have two class I CFTR variants欧洲药品管理局对Kaftrio（elexacaftor-tezacaftor-ivacaftor）的审查：将其适用范围扩展至所有年龄在2岁及以上且不携带两种class I CFTR变异的CF患者。
errEuropean Respiratory Journal
IF21
err2026-01-01
err1
PREAI
errDrai, Catherine; van der Woude, Hanneke J.; Lexmond, Anne J.; van den Hoorn, Tineke; Mol, Peter G. M.; Leacy, Finbarr P.; Przybyszewska, Agnieszka; Sepodes, Bruno; Castelnovo, Thomas
err分享
err收藏
Impact of adding immune checkpoint inhibitors to standard therapies in non-small cell lung cancer: A systematic review of efficacy outcomes在非小细胞肺癌标准治疗中添加免疫检查点抑制剂的影响: 疗效结果的系统评价
errCritical Reviews in Oncology/Hematology
IF0
err2025-12-19
err0
PREAI
errAna Pinto Correia; Adriana Marques; Bruno Sepodes; Carla Torre; João Rocha
err分享
err收藏
European Medicines Agency seeks stakeholders' views on its reflection paper on patient experience data欧洲药品管理局寻求利益相关方对其关于患者体验数据的反思论文的意见。
errBritish Journal of Clinical Pharmacology
IF3
err2025-11-05
err0
errOAAI
errRosa Gonzalez-Quevedo; Juan Garcia Burgos; Marco Greco; Sabine Straus; Ulla Wändel Liminga; Bruno Sepodes
err分享
err收藏
Regulation of inflammatory pathways by cannabigerol in the collagen induced arthritis model in rats大麻素酸对胶原诱导性关节炎大鼠模型中炎症通路的调控
errFrontiers in Pharmacology
IF4.8
err2025-10-28
err0
errOAAI
errMonika Šteigerová‡; Michaela Sklenárová‡; Mykhaylo Bazyuk; Luděk Záveský; Petr Jelínek; Mahak Arora; Daniel Stránský; Tomáš Kučera; Bruno Sepodes; Miroslav Šoóš; Martin Šíma†; Ondřej Slanař†
err分享
err收藏
Novel approaches to the stratified management of knee osteoarthritis分层管理膝关节骨关节炎的新方法
errNature Reviews Rheumatology
IF32.7
err2025-10-03
err0
PREAI
errNicholas R. Fuggle; Roland Chapurlat; Andrea Laslop; Nasser Al-Daghri; Majed Alokail; Jotheeswaran Amuthavalli Thiyagarajan; Ewa Balkowiec-Iskra; Francis Berenbaum; Angie Botto-van Bemden; John-Joseph Borg; Olivier Bruyère; Nansa Burlet; Etienne Cavalier; Mario M. Rosa; Philip G. Conaghan; Cyrus Cooper; Elaine M. Dennison; Martin Englund; Gun-il Im; Ida K. Haugen; Mickaël Hiligsmann; Andreas Kurth; Nancy Lane; Rik Lories; Stefan Marlovits; Radmila Matijevic; Ali Mobasheri; Sif Ormarsdóttir; Maria C. Prieto Yerro; Régis P. Radermecker; François Rannou; Bruno Sepodes; Stuart Silverman; Carla Torre; Nicola Veronese; René Rizzoli; Jean-Yves Reginster; Nicholas C. Harvey
err分享
err收藏
European medicines agency approvals of new medicines in July and August 2025欧洲药品管理局于2025年7月和8月批准的新药
errThe Lancet Regional Health - Europe
IF0
err2025-09-24
err0
errOAAI
errBruno Sepodes; Juan Garcia Burgos; Steffen Thirstrup
err分享
err收藏
Oral Salvia officinalis phenolics abolish mortality and mitigate inflammation in acute TNBS murine colitis口服药用鼠尾草酚类物质可消除急性三硝基苯磺酸诱导的小鼠结肠炎的死亡率并减轻炎症
errFitoterapia
IF2.6
err2025-09-15
err0
PREAI
errRosa Direito; João Rocha; Inês Alves de Melo; Margarida Gonçalves; Maria Paula Duarte; Adelaide Fernandes; Bruno Sepodes; Maria-Eduardo Figueira
err分享
err收藏
Real-World Data Included in Post-authorisation Measures: A Case Study of Approved Advanced Therapy Medicinal Products in the European Union between 2013 and 2024真实世界数据纳入上市后措施：一项关于2013年至2024年欧盟批准的先进治疗药品的案例研究
errBioDrugs
IF6.9
err2025-08-26
err0
errOAAI
errDiogo Almeida; Diana Mandslay; Peter G. M. Mol; Bruno Sepodes; Carla Torre
err分享
err收藏
The European Medicines Agency evaluation of nemolizumab (Nemluvio) for the treatment of moderate-to-severe atopic dermatitis and prurigo nodularis欧洲药品管理局对nemolizumab（Nemluvio）治疗中重度特应性皮炎和结节性痒疹的评估
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2025-08-01
err0
errOAAI
errKristyanto, Hendy; Torre, Sagrario Rey; Cunney, Anna; Dunder, Kristina; Bego, Margareta; Sepodes, Bruno; Castelnovo, Thomas
err分享
err收藏
Applying the EU Regulatory Framework to Determine the Benefit–Risk Profile of Psychedelics应用欧盟监管框架来确定迷幻药的利益-风险评估概况
errACS Pharmacology & Translational Science
IF3.7
err2025-07-18
err0
errOAAI
errKate Browne; Ewa Bałkowiec-Iskra; Andre Elferink; Marion Haberkamp; Sabine Straus; Bruno Sepodes; Francisca Silva; Florence Butlen-Ducuing; Jarno Jansen; Ivana Silva; Pavel Balabanov; Juan Garcia Burgos; Steffen Thirstrup
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
C
Cyrus Cooper
H 指数: 236 · 论文数: 3.2K
A
Anthony Cerami
H 指数: 148 · 论文数: 685
J
Jean‐Yves Reginster
H 指数: 120 · 论文数: 1.9K
R
René Rizzoli
H 指数: 120 · 论文数: 823
P
Philip G. Conaghan
H 指数: 116 · 论文数: 1.2K
查看更多